What is already known about this topic?
COVID-19 vaccination during pregnancy is recommended to prevent severe illness and death in pregnant women. Infants are at risk for COVID-19–associated complications, including respiratory failure and other life-threatening complications.
What is added by this report?
Effectiveness of maternal completion of a 2-dose primary mRNA COVID-19 vaccination series during pregnancy against COVID-19 hospitalization among infants aged <6 months was 61% (95% CI = 31% to 78%). Effectiveness of completion of the primary COVID-19 vaccine series early and later in pregnancy was 32% (95% CI = –43% to 68%) and 80% (95% CI = 55% to 91%), respectively.
What are the implications for public health practice?
Completion of a 2-dose mRNA COVID-19 vaccination series during pregnancy might help prevent COVID-19 hospitalization among infants aged <6 months.
Entire content available on: https://www.cdc.gov/mmwr/volumes/71/wr/mm7107e3.htm
Lingua
IngleseTipologia
Articoli scientifici/ReviewsArgomento
Covid-19 VacciniProfilo
Salute pubblicaPaese
USA